These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36461873)

  • 21. Decoding "guitar pick sign" in COVID-19-associated mucormycosis: A case series.
    Reddy YM; Parida S; Reddy SB; Yeduguri S; Pidaparthi L; Jaiswal SK; Sadhvani B; Murthy JMK
    Indian J Ophthalmol; 2022 Apr; 70(4):1425-1427. PubMed ID: 35326073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucormycosis in patients with renal failure.
    Gupta KL; Radotra BD; Sakhuja V; Banerjee AK; Chugh KS
    Ren Fail; 1989-1990; 11(4):195-9. PubMed ID: 2485482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete and incomplete lower motor neuron facial palsy in post-COVID-19 mucormycosis.
    Gautam M; Soni M; Bhaisare V; Rawat P; Walia S; Kori N
    Indian J Ophthalmol; 2022 Apr; 70(4):1365-1370. PubMed ID: 35326056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral Mucormycosis in Context with COVID-19 Infection.
    Shastri M; Raval DM; Rathod VM
    J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082737
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to: COVID-19-associated mucormycosis and evolving evidence.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346
    [No Abstract]   [Full Text] [Related]  

  • 26. Initial and ongoing challenges with COVID-19-associated mucormycosis.
    Sikka K; Goel G; Sharma N; Thakar A
    Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965
    [No Abstract]   [Full Text] [Related]  

  • 27. 'Black turbinates' in COVID-associated sino-nasal mucormycosis.
    Ghonge NP; Nagpal K; Malla S
    QJM; 2022 Dec; 115(12):851-852. PubMed ID: 35959989
    [No Abstract]   [Full Text] [Related]  

  • 28. Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
    Arora N; Gudipati A; Kundu R; Prabhakar N; Suri V; Malhotra P; Jain A
    Lancet Infect Dis; 2021 Nov; 21(11):1611. PubMed ID: 34717815
    [No Abstract]   [Full Text] [Related]  

  • 29. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
    Soman R; Sunavala A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262
    [No Abstract]   [Full Text] [Related]  

  • 30. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
    Garg D; Muthu V; Sehgal IS; Ramachandran R; Kaur H; Bhalla A; Puri GD; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 May; 186(2):289-298. PubMed ID: 33544266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
    Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
    Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature.
    Ostovan VR; Rezapanah S; Behzadi Z; Hosseini L; Jahangiri R; Anbardar MH; Rostami M
    J Neurovirol; 2021 Aug; 27(4):644-649. PubMed ID: 34342852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post coronavirus disease- 19 invasive renal and gastrointestinal mucormycosis.
    Vadi S; Raut A; Shah S; Ismail AM
    Indian J Med Microbiol; 2022; 40(3):462-464. PubMed ID: 35527119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhino-orbital mucormycosis in a COVID-19 patient.
    Baskar HC; Chandran A; Reddy CS; Singh S
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167998
    [No Abstract]   [Full Text] [Related]  

  • 35. Mucormycosis in COVID-19 recovered patients.
    Kumar A
    J Med Virol; 2022 Apr; 94(4):1272-1273. PubMed ID: 34905224
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.
    Bonates P; João GAP; Cruz KS; Ferreira MS; Baía-da-Silva DC; Farias MEL; Brito-Sousa JD; Santana MF; Oliveira LA; Cortez ACA; Souza JVB; Lacerda MVG
    Rev Soc Bras Med Trop; 2021; 54():e03582021. PubMed ID: 34259759
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases.
    Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S
    QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023
    [No Abstract]   [Full Text] [Related]  

  • 38. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral mucormycosis in post-COVID-19 patients: A case series.
    Ahmed E; Abou-Bakr A; Hussein RR; El-Gawish AA; Ras AE; Ghalwash DM
    Oral Dis; 2022 Nov; 28 Suppl 2():2591-2592. PubMed ID: 34289206
    [No Abstract]   [Full Text] [Related]  

  • 40. Should statins be considered for the management of mucormycosis in COVID-19?
    Chatterjee S; Vardhan B; Singh DK; Maitra A; Ojha UK
    Diabetes Metab Syndr; 2021; 15(4):102162. PubMed ID: 34186353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.